Bergsagel PL - Search Results

1

Expression of NrasQ61R and MYC transgene in germinal center B cells induces a highly malignant multiple myeloma in mice.

Wen Z, Rajagopalan A, Flietner ED, Yun G, Chesi M, Furumo Q, Burns RT, Papadas A, Ranheim EA, Pagenkopf AC, Morrow ZT, Finn R, Zhou Y, Li S, You X, Jensen J, Yu M, Cicala A, Menting J, Mitsiades CS, Callander NS, Bergsagel PL, Wang D, Asimakopoulos F, Zhang J. Wen Z, et al. Among authors: bergsagel pl. Blood. 2021 Jan 7;137(1):61-74. doi: 10.1182/blood.2020007156. Blood. 2021. PMID: 32640012 Free PMC article.

2

Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.

Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM. Chesi M, et al. Among authors: bergsagel pl. Blood. 1996 Jul 15;88(2):674-81. Blood. 1996. PMID: 8695815 Free article.

3

Selective expression of one c-myc allele in two human myeloma cell lines.

Kuehl WM, Brents LA, Chesi M, Bergsagel PL. Kuehl WM, et al. Among authors: bergsagel pl. Cancer Res. 1996 Oct 1;56(19):4370-3. Cancer Res. 1996. PMID: 8813127

4

Dysregulation of c-myc in multiple myeloma.

Kuehl WM, Brents LA, Chesi M, Huppi K, Bergsagel PL. Kuehl WM, et al. Among authors: bergsagel pl. Curr Top Microbiol Immunol. 1997;224:277-82. doi: 10.1007/978-3-642-60801-8_29. Curr Top Microbiol Immunol. 1997. PMID: 9308252

5

IgH translocations in multiple myeloma: a nearly universal event that rarely involves c-myc.

Bergsagel PL, Nardini E, Brents L, Chesi M, Kuehl WM. Bergsagel PL, et al. Curr Top Microbiol Immunol. 1997;224:283-7. doi: 10.1007/978-3-642-60801-8_30. Curr Top Microbiol Immunol. 1997. PMID: 9308253

6

Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma.

Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T, Schröck E, Ried T, Kuehl WM. Chesi M, et al. Among authors: bergsagel pl. Blood. 1998 Jun 15;91(12):4457-63. Blood. 1998. PMID: 9616139 Free article.

7

The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.

Chesi M, Nardini E, Lim RS, Smith KD, Kuehl WM, Bergsagel PL. Chesi M, et al. Among authors: bergsagel pl. Blood. 1998 Nov 1;92(9):3025-34. Blood. 1998. PMID: 9787135 Free article.

8

Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis.

Plowright EE, Li Z, Bergsagel PL, Chesi M, Barber DL, Branch DR, Hawley RG, Stewart AK. Plowright EE, et al. Among authors: bergsagel pl. Blood. 2000 Feb 1;95(3):992-8. Blood. 2000. PMID: 10648414 Free article.

9

Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.

Chesi M, Kuehl WM, Bergsagel PL. Chesi M, et al. Among authors: bergsagel pl. Ann Oncol. 2000;11 Suppl 1:131-5. Ann Oncol. 2000. PMID: 10707795 Review.

10

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma.

Chesi M, Brents LA, Ely SA, Bais C, Robbiani DF, Mesri EA, Kuehl WM, Bergsagel PL. Chesi M, et al. Among authors: bergsagel pl. Blood. 2001 Feb 1;97(3):729-36. doi: 10.1182/blood.v97.3.729. Blood. 2001. PMID: 11157491 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results